US Stem Cell Inc (USRM)

[Xpecht]

So let’s get this straight, record revenues released and within a day the PR on this SEC investigation which happened concurrent with Senator Grassley’s comments and the DOJ lawsuit. This took the stock from .07 to .02 back in April 2018, and was a year long investigation with no recommended actions?

Was this an “investigation” or an insurance policy in case USRM wins the lawsuit?

I am sure anyone who followed the timing and coordination of all of this have learned a lot here.